X
144188195215245280

Ncord Biotech Limited

Pune, Maharashtra

| GST  27AADCN5780C2ZG

| Verified Supplier

View Mobile Number
NCORD Biotech is India’s largest stem cell provider focusing on advancing regenerative medicine sector, cellular product development, and clinical translation of products.
The main aim of the company is to bridge the gap between the stem cell researchers and hospitals/ clinicians, thereby making available the life-saving stem cell therapies to the patients.
+ Read More

Nature of Business

Nursing Homes / Clinics / Hospitals

Legal Status of Firm

Limited Company (Ltd. / Pvt. Ltd.)

GST Number

27AADCN5780C2ZG

Hope Of Cure For Arthritis
Interested in this product?
Get Best Quote

REVOLUTIONARY stem cell therapy could end the suffering of millions of arthritis patients

REVOLUTIONARY stem cell therapy could end the suffering of millions of arthritis patients. Preliminary findings of a trial of the treatment show that within days patients experienced a dramatic reduction in pain. Sufferers’ own stem cells were injected into their knees resulting in significantly increased joint function. Osteoarthritis affects 14 per cent of over 25s and a third of all pensioners. It causes severe and chronic pain, joint stiffness and loss of function. Currently there is no drug, medical intervention or therapy that alters its progression and many patients have to take painkillers constantly and ultimately need total joint replacement surgery. The new technique involves removing a small sample of fat from the body from which stem cells are separated out and grown over several weeks until they are injected into the area of joint damage. The trial involved 18 patients given a single injection of cultured stem cells. The results were so successful that researchers have amplified the study to recruit 150 patients from 10 hospitals for a largescale multi-million pound follow-up in Ireland, France, the UK, Germany, Italy and the Netherlands.

View Complete Details

Yes, I am interested!

Hope Of Cure Arthritis Treatment Services
Interested in this product?
Get Best Quote
Hope Of Cure For Arthritis Treatment Service
Hope of cure for Arthritis

REVOLUTIONARY stem cell therapy could end the suffering of millions of arthritis patients

REVOLUTIONARY stem cell therapy could end the suffering of millions of arthritis patients. Preliminary findings of a trial of the treatment show that within days patients experienced a dramatic reduction in pain. Sufferers’ own stem cells were injected into their knees resulting in significantly increased joint function. Osteoarthritis affects 14 per cent of over 25s and a third of all pensioners

View Complete Details

Yes, I am interested!

Vision Restoration Treatment Service
Interested in this product?
Get Best Quote
Researchers have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses.

Researchers have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses. The treatment, which has been tested in animals and in a small, human clinical trial, produced much fewer surgical complications than the current standard-of-care and resulted in regenerated lenses with superior visual function in all 12 of the pediatric cataract patients who received the new surgery. “The success of this work represents a new approach in how new human tissue or organ can be regenerated and human disease can be treated, and may have a broad impact on regenerative therapies by harnessing the regenerative power of our own body,”

View Complete Details

Yes, I am interested!

Vision Restoration
Interested in this product?
Get Best Quote

Vision Restoration

Get Latest Price

Researchers have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses.

Researchers have developed a new, regenerative medicine approach to remove congenital cataracts in infants, permitting remaining stem cells to regrow functional lenses. The treatment, which has been tested in animals and in a small, human clinical trial, produced much fewer surgical complications than the current standard-of-care and resulted in regenerated lenses with superior visual function in all 12 of the pediatric cataract patients who received the new surgery. “The success of this work represents a new approach in how new human tissue or organ can be regenerated and human disease can be treated, and may have a broad impact on regenerative therapies by harnessing the regenerative power of our own body,”

View Complete Details

Yes, I am interested!

Get Price & Details
Tell us what you
need
Receive seller
details
Seal the deal
Save time! Get Best Deal
I agree to the terms and privacy policy